These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 231585)

  • 1. Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages.
    Bachrach HL; Morgan DO; Moore DM
    Intervirology; 1979; 12(2):65-72. PubMed ID: 231585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.
    Bachrach HL; Morgan DO; McKercher PD; Moore DM; Robertson BH
    Vet Microbiol; 1982 May; 7(2):85-96. PubMed ID: 6287701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.
    Kaaden OR; Adam KH; Strohmeier K
    J Gen Virol; 1977 Feb; 34(2):397-400. PubMed ID: 65445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
    Robertson BH; Moore DM; Grubman MJ; Kleid DG
    J Virol; 1983 Apr; 46(1):311-6. PubMed ID: 6186823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
    Borca MV; Moore DM; Srikumaran S; Morgan DO
    Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal amino acid sequences in the major capsid proteins of foot-and-mouth disease virus types A, O, and C.
    Matheka HD; Bachrach HL
    J Virol; 1975 Nov; 16(5):1248-53. PubMed ID: 171452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.
    Cavanagh D; Sangar DV; Rowlands DJ; Brown F
    J Gen Virol; 1977 Apr; 35(1):149-58. PubMed ID: 192841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location and characterization of the antigenic portion of the FMDV immunizing protein.
    Strohmaier K; Franze R; Adam KH
    J Gen Virol; 1982 Apr; 59(Pt 2):295-306. PubMed ID: 6176678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the minor polypeptides in the foot-and-mouth disease particle.
    Sangar DV; Rowlands DJ; Cavanagh D; Brown F
    J Gen Virol; 1976 Apr; 31(1):35-46. PubMed ID: 177728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships in foot-and-mouth disease virus.
    Brown F
    Adv Exp Med Biol; 1972; 31(0):19-28. PubMed ID: 4369223
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity.
    Moore DM; Cowan KM
    J Gen Virol; 1978 Dec; 41(3):549-62. PubMed ID: 84854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
    Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological priming with synthetic peptides of foot-and-mouth disease virus.
    Francis MJ; Fry CM; Rowlands DJ; Brown F; Bittle JL; Houghten RA; Lerner RA
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2347-54. PubMed ID: 2997370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus].
    Rar VA; Makarov EA; Iurovskiĭ VV; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1990 Jul; 16(7):904-15. PubMed ID: 2173604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of the structural polypeptides of foot-and-mouth disease virus and analysis of their C-terminal sequences.
    Bachrach HL; Swaney JB; Vande Woude GF
    Virology; 1973 Apr; 52(2):520-8. PubMed ID: 4350226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.